secwatch / observer
8-K filed May 1, 2024, 7:59 PM ET ticker CVS CIK 0000064803
earnings confidence high sentiment negative materiality 0.85

CVS Health Q1 GAAP EPS $0.88 vs $1.65; FY2024 guidance slashed on Medicare pressure

CVS HEALTH Corp

2024-Q1 EPS reported $0.88 revenue$88,437,000,000

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.95

CVS HEALTH Corp reported full-year 2024 results: EPS Revised GAAP diluted EPS guidance to at least $5.64 from at least $7.06. Guidance lowered.

Period
full-year 2024
EPS
Revised GAAP diluted EPS guidance to at least $5.64 from at least $7.06
Guidance
lowered
Result
guidance update
Exact text from the filing
Revised GAAP diluted EPS guidance to at least $5.64 from at least $7.06
View on SEC.gov
Earnings Releases SEC 8-K Item 2.02 confidence 0.95

CVS HEALTH Corp reported the three months ended March 31, 2024 results: revenue $88,437, EPS $0.88.

Period
the three months ended March 31, 2024
Revenue
$88,437
EPS
$0.88
Result
reported results
Exact text from the filing
results for the three months ended March 31, 2024. Financial Results Summary Three Months Ended March 31, In millions, except per share amounts 2024 2023 Change Total revenues $ 88,437 $ 85,278 $ 3,159 Operating income 2,271 3,446 (1,175) Adjusted operating income (1) 2,957 4,370 (1,413) Diluted earnings per share $ 0.88 $ 1.65 $ (0.77) Adjusted EPS (2) $ 1.31 $
View on SEC.gov

379 earnings releases filed in the last 30 days. Browse all earnings releases →

CVS HEALTH Corp filing history →

Source: SEC EDGAR
accession 0000064803-24-000015
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.